WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD - News), a leading provider of data management solutions for clinical trials and drug safety, will participate in six industry events this month including the ChinaTrials Global Clinical Development Summit and CBI’s 5th Forum on Patient Reported Outcomes (PRO).
At the ChinaTrials Global Clinical Development Summit, November 8-10, in Beijing, China, Phase Forward (booth # 22) Regional Director and General Manager Jon Carrano will moderate a panel on EDC in China. Session details are as follows:
Who: Jon Carrano, Ph.D., Regional Director and General Manager,
Phase Forward (Moderator)
What: “Electronic Data Capture and
Clinical Data Management in China”
When: Tuesday, November
10, 10:10-11:10 a.m. local time
At CBI’s 5th Forum on Patient Reported Outcomes, November 17-18, in Philadelphia, Pa., Phase Forward will exhibit its late phase solutions and Vice President and Conference Chair Scott Dixon will participate in the following session:
Who: Scott Dixon, Vice President, Outcome Logix Group, Phase
Forward (Moderator)
What: “Recall Period – What Works and
What Doesn’t?”
When: Wednesday, November 18, 9:00-9:45 a.m.
Eastern time
As Conference Chair, Mr. Dixon will also deliver opening remarks on the first day of the conference at 1:15 p.m. and on the second day at 8:00 a.m.
In addition to its speaking engagements, Phase Forward will participate in the following conferences throughout the month of November:
What: 8th
Annual Partnerships in Clinical Trials
When: November
4-5, Rotterdam, The Netherlands
Where: Booth # 71
What: American
Association of Pharmaceutical Scientists Annual Meeting and Exposition
(AAPS)
When: November 8-12, Los Angeles, Calif.
Where:
Booth # 702
What: CDISC
Interchange North America
When: November 9-13,
Baltimore, Md.
Where: Booth # 7
What: 2nd
DIA Conference on Signal Detection and Data Mining
When:
November 16-18, New York, N.Y.
Members of the media interested in speaking with Phase Forward should contact Maria Sumner at +44 1628 640743 or maria.sumner@phaseforward.com or Meghan Locke at 781-672-3147 or mlocke@chenpr.com.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 300 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
Phase Forward
Elaine Maynard, 781-902-4371
elaine.maynard@phaseforward.com
or
CHEN PR, Inc.
Meghan Locke, 781-672-3147
mlocke@chenpr.com
Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.